Literature DB >> 2938660

A phase I study of the combined hypoxic cell radiosensitizers, Ro 03-8799 and SR 2508: a preliminary report of single-dose toxicity, pharmacokinetics and tumour concentrations.

H F Newman, N M Bleehen, P Workman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 2938660     DOI： 10.1259/0007-1285-59-700-423

Source DB:  PubMed          Journal:  Br J Radiol        ISSN： 0007-1285            Impact factor:   3.039


× No keyword cloud information.
  3 in total

1.  When can the infusion period be safely ignored in the estimation of pharmacokinetic parameters of drugs in humans?

Authors:  L S Freedman; P Workman
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

2.  Lack of stereoselectivity in the pharmacokinetics and metabolism of the radiosensitizer Ro 03-8799 in man.

Authors:  P Workman; H F Newman; N M Bleehen; R Ward; C E Smithen
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

3.  Relationship between the melanin content of a human melanoma cell line and its radiosensitivity and uptake of pimonidazole.

Authors:  R el Gamoussi; M D Threadgill; M Prade; I J Stratford; M Guichard
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.